Related Experiment Video
Updated: Jun 16, 2025

Noninvasive, High-throughput Determination of Sleep Duration in Rodents
Published on: April 18, 2018
Outcome of Sleep Rehabilitation in Autistic Children with Sleep Disorders Is Linked to Melatonin Receptor Genes SNPs
Elisabetta Bolognesi1, Alessandra Carta2, Franca Rosa Guerini1
1IRCCS Fondazione Don Carlo Gnocchi ONLUS, Laboratory of Molecular Medicine and Biotechnology, 20148 Milan, Italy.
Insights
Genetic variants in melatonin receptor genes MT1 and MT2 are linked to sleep problems in children with Autism Spectrum Disorder (ASD). These single nucleotide polymorphisms (SNPs) may predict sleep disorder severity and guide tailored treatments.
Area of Science:
- Genetics and Neuroscience
- Pediatric Sleep Medicine
- Autism Spectrum Disorder Research
Background:
- Autism Spectrum Disorder (ASD) is frequently associated with sleep disturbances, impacting quality of life.
- Melatonin signaling, regulated by MT1 and MT2 receptors, plays a crucial role in sleep-wake cycles.
- Understanding the genetic underpinnings of sleep issues in ASD is vital for developing effective interventions.
Purpose of the Study:
- To investigate the association between single nucleotide polymorphisms (SNPs) in the MT1 and MT2 melatonin receptor genes and Autism Spectrum Disorder (ASD).
- To determine if these genetic variants correlate with ASD susceptibility, clinical severity, and specific sleep problems.
- To evaluate the predictive value of these SNPs for treatment outcomes in children with ASD and sleep disturbances.
Main Methods:
- Genotyping of six SNPs in MT1 and MT2 genes in 139 ASD children, 82 siblings, and 53 healthy controls of Sardinian ancestry.
- Assessment of sleep problems using the Sleep Disturbance Scale for Children (SDSC).
- Correlation analysis between SNP genotypes and clinical severity/sleep problem scores (DIMS, DA, SHY), including evaluation of treatment outcomes.
Main Results:
- The MT2 rs10830963 G allele was more prevalent in ASD children and siblings than controls.
- SNPs rs2119882 (MT1) and rs1562444 (MT2) were associated with sleep problems like Difficulty in Falling Asleep (DIMS), Daytime Awakenings (DA), and Sleep Habits (SHY).
- Specific alleles (rs2119882 T, rs1562444 A) correlated with higher severity scores, and homozygous carriers showed less improvement after rehabilitative treatment.
Conclusions:
- MT1 and MT2 gene variants may serve as predictive genetic markers for sleep disorder severity in children with ASD.
- These findings suggest a potential genetic basis for sleep disturbances in ASD, influencing treatment response.
- Personalized rehabilitative strategies targeting sleep issues in ASD could be informed by these genetic insights.
Abstract:
A significant proportion of children with Autism spectrum disorder (ASD) experience sleep issues, such as insomnia and other disorders, as assessed by the Sleep Disturbance Scale for Children. Our study investigated the link between six single nucleotide polymorphisms (SNPs) in the melatonin receptor genes MT1 and MT2 and ASD susceptibility, clinical severity and associated sleep problems. A total of 139 ASD children, 82 siblings, and 53 unrelated healthy controls, all of Sardinian ancestry, were studied; among them, 38 children with co-occurring sleep issues were assessed for the outcomes of a rehabilitative program, including behavioral therapy and sleep hygiene. The MT2 rs10830963 G allele is more prevalent in ASD children and their siblings compared to the healthy controls, while rs2119882 (MT1) and rs1562444 (MT2) are associated with DIMS, DA, and SHY. ASD Children carrying the rs2119882 T allele have higher scores for DIMS and DA compared to C allele carriers, and those carrying rs1562444 A allele have higher scores for SHY than G allele carriers. After rehabilitative treatment, homozygous TT carriers of rs2119882 showed less improvement in DIMS symptoms compared to CT and CC carriers. A similar result was observed for AA carriers of SNP rs1562444 about SHY. We may suggest that the MT1 and MT2 variants may serve as useful predictive genetic markers for the severity of sleep disorders in children with ASD, potentially informing the design of more targeted rehabilitative treatments.
Related Concept Videos
Management of Insomnia
Narcolepsy
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
REM Sleep Behavior Disorder
RBD is significantly associated with...
Understanding Sleep
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...
Sleep-Wake Cycles
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:

